| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |